<DOC>
	<DOCNO>NCT02247934</DOCNO>
	<brief_summary>The objective qualitative study elicit concept symptom important patient primary sclerosing cholangitis ( PSC ) , well key impact symptoms patient ' day-to-day functioning .</brief_summary>
	<brief_title>Development Patient-Reported Outcome Measure Assess Symptoms Patients With Primary Sclerosing Cholangitis ( PSC )</brief_title>
	<detailed_description>In Step I , concept elicitation one-on-one interview ( via telephone person ) conduct . The aim concept elicitation interview : 1 . Identify common symptom , well important symptom , patient PSC , 2 . Assess whether symptoms impact day-to-day function An instrument develop base symptom report Step II study , performance instrument assess interview .</detailed_description>
	<mesh_term>Cholangitis</mesh_term>
	<mesh_term>Cholangitis , Sclerosing</mesh_term>
	<criteria>Confirmed diagnosis PSC base liver biopsy diagnostic imaging , diagnosis make least three month prior screen Patient report PSC symptom associate PSC diagnosis Able speak , read , understand English Willing able provide write informed consent participate research study Patients cause liver biliary disease , include viral hepatitis , alcoholic liver disease , primary biliary cirrhosis , secondary sclerosing cholangitis Patient history liver cirrhosis Patients history cholangiocarcinoma Patients receive liver transplant Patients currently enrol PSC clinical trial ; STEP II ONLY : Enrolled participated Step I study ( concept elicitation )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>February 2016</verification_date>
	<keyword>Primary sclerosing cholangitis</keyword>
	<keyword>PSC</keyword>
</DOC>